Expansion of avian influenza vaccine plant in 6th of October City

VACSERA, through its subsidiary EgyVet, is completing major expansion works on the avian influenza vaccine plant located in the 6th of October Industrial Zone.

The new GMP-compliant facility has a target capacity of 800 million doses annually. It is optimized for inactivated H5N1 avian influenza vaccines and egg-based viral vaccine formulations.

This project is a critical element of Egypt's agricultural security, protecting the local poultry wealth and preventing potential avian-to-human virus mutations.